Role of Glutathione in Cancer Progression and Chemoresistance
Top Cited Papers
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2013, 1-10
Abstract
Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and disturbances in GSH homeostasis are involved in the etiology and progression of many human diseases including cancer. While GSH deficiency, or a decrease in the GSH/glutathione disulphide (GSSG) ratio, leads to an increased susceptibility to oxidative stress implicated in the progression of cancer, elevated GSH levels increase the antioxidant capacity and the resistance to oxidative stress as observed in many cancer cells. The present review highlights the role of GSH and related cytoprotective effects in the susceptibility to carcinogenesis and in the sensitivity of tumors to the cytotoxic effects of anticancer agents.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (2009M8FKBB_002)
- Università degli Studi di Genova (2009M8FKBB_002)
This publication has 123 references indexed in Scilit:
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and OpportunitiesAntioxidants & Redox Signaling, 2009
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Pharmacology of a mimetic of glutathione disulfide, NOV-002Biomedicine & Pharmacotherapy, 2009
- Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsBioorganic & Medicinal Chemistry, 2008
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences, 2008
- Heme Oxygenase-1 in Tumors: Is It a False Friend?Antioxidants & Redox Signaling, 2007
- Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxideProceedings of the National Academy of Sciences, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007